These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11219321)

  • 1. Linezolid.
    French G
    Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
    Krueger WA; Unertl KE
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of linezolid in children: an overview of recent advances.
    Velissariou IM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
    Wilcox MH
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
    Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
    Ament PW; Jamshed N; Horne JP
    Am Fam Physician; 2002 Feb; 65(4):663-70. PubMed ID: 11871684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
    Sztanke K; Pasternak K; Sztanke M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW; Kucia ML; Salata RA
    Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid, the first oxazolidinone antibacterial agent.
    Leach KL; Brickner SJ; Noe MC; Miller PF
    Ann N Y Acad Sci; 2011 Mar; 1222():49-54. PubMed ID: 21434942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of linezolid in pediatrics: a critical review.
    Dotis J; Iosifidis E; Ioannidou M; Roilides E
    Int J Infect Dis; 2010 Aug; 14(8):e638-48. PubMed ID: 20106697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Linezolid: antibacterial activity, clinical efficacy and resistance].
    Bourgeois-Nicolaos N; Piriou O; Butel MJ; Doucet-Populaire F
    Ann Biol Clin (Paris); 2006; 64(6):549-64. PubMed ID: 17162258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experience with linesolid usage in newborn children].
    Atanasova V; Slavkova N; Rosmanova R
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.